Medical News

RSS

Researchers identify ten new antibodies that can possibly prevent cancer tumours

Out of a library with billions of artificial antibodies, researchers have identified ten that can possibly prevent cancer tumours from growing.

20 Jan 2015

Study on influenza B viruses could help make flu vaccination programs more effective

An analysis of 10 years' worth of data on human influenza B viruses has shed new light on the pathogen which can cause the seasonal flu. Findings from this study could help make flu immunization programs more effective; by better targeting vaccines or by eventually eliminating one of the flu lineages completely.

20 Jan 2015

EvergreenHealth recognized as Distinguished Hospital for Clinical Excellence

EvergreenHealth has achieved its sixth designation as a Distinguished Hospital for Clinical Excellence from Healthgrades, placing the health care organization among the top 5 percent of hospitals of the more than 4,500 hospitals evaluated nationwide and based solely on its outstanding clinical performance.

20 Jan 2015

LUME-Lung 1 shows QoL, symptoms benefits

LUME-Lung 1 trial patients’ reports of symptoms and health-related quality of life support the use of second-line nintedanib for the treatment of advanced non-small-cell lung cancer.

20 Jan 2015

Amrubicin, carboplatin duo efficacious in thymic carcinoma, not invasive thymoma

Combination therapy with amrubicin and carboplatin is moderately effective in patients with advanced thymic carcinoma, a Japanese study finds, but invasive thymoma patients do not benefit from this regimen.

20 Jan 2015

MET amplified in NSCLC irrespective of type, genetic background

A third of non-small-cell lung cancers show low- to high-level amplification of the MET gene, according to a German study, with no significant difference in frequency across different types of cancer and genetic backgrounds.

20 Jan 2015

Rare, complex EGFR mutations adversely affect EGFR–TKI treatment outcomes

Individuals with advanced non-small-cell lung cancer who have rare or complex epidermal growth factor receptor mutations have inferior outcomes in response to EGFR–tyrosine kinase inhibitor treatment compared with those with common mutations, research indicates.

20 Jan 2015

Income, race and ethnic origin may play more potent roles in asthma risk

Challenging the long-standing belief that city dwellers suffer disproportionately from asthma, the results of a new Johns Hopkins Children's Center study of more than 23,000 U.S. children reveal that income, race and ethnic origin may play far more potent roles in asthma risk than kids' physical surroundings.

20 Jan 2015

Kinex Pharmaceuticals doses first actinic keratosis patient with KX2-391 ointment

Kinex Pharmaceuticals announced today that the first actinic keratosis patient has been dosed with KX2-391 ointment in Austin, Texas.

20 Jan 2015

NeoDeck, DataMotion partner for secure messaging of clinical and non-clinical information

FNeoDeck Holdings, Puerto Rico's leading provider of healthcare management solutions, today announced it has partnered with DataMotion, an accredited health information service provider (HISP) supplying email encryption solutions for clinical and non-clinical exchange of protected health information (PHI).

20 Jan 2015

TPI obtains GMP certification for Qionglai Tianyin Facility

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that the TPI's Qionglai Tianyin Facility (QLF) has received its Good Manufacturing Practice (GMP) certificate from the China Food & Drug Administration's (CFDA) with the GMP certification processing number: SC20140067.

20 Jan 2015

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson today announced sales of $18.3 billion for the fourth quarter of 2014, a decrease of 0.6% as compared to the fourth quarter of 2013. Operational results increased 3.9% and the negative impact of currency was 4.5%. Domestic sales increased 7.4%.

20 Jan 2015

EarlySense completes $20 million financing round

EarlySense Ltd., the market leader in contact-free monitoring, announced today that it has completed a $20 million financing round, led by Samsung Ventures with an investment of $10M. Existing investors whose participation was also substantial include Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber.

20 Jan 2015

Celator Pharmaceuticals' CPX-351 receives FDA Fast Track designation for secondary AML treatment

Celator Pharmaceuticals, Inc., a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced that the U.S. Food and Drug Administration granted Fast Track designation for CPX-351 (cytarabine:daunorubicin) for the treatment of elderly patients with secondary Acute Myeloid Leukemia (AML).

20 Jan 2015

Researchers explore how M6P deficiency affects different kinds of immune cells

A group of white blood cells known as B cells, which play a key role in the human immune response, need a protein-targeting signal called mannose 6-phosphate (M6P) in order to proliferate, differentiate, and present immune cell-activating antigens, according to a study in The Journal of Cell Biology.

20 Jan 2015

UPM researchers study stability of arsenic species in edible marine algae

Researchers at UPM have studied the stability of diverse arsenic species found in edible marine algae and have established the best conditions for their storage and preservation.

20 Jan 2015

St. Luke’s offers Frameless Stereotactic Radiosurgery for treatment of brain tumors

Some treatments for brain and spine tumors traditionally have involved restraining a patient with a heavy immobilization device and pins that pierce the skin and embed into the skull to ensure the accuracy and precision of a treatment. Doctors say the pins can add considerable anxiety.

20 Jan 2015

FDA removes partial clinical hold on CytRx's aldoxorubicin clinical trials

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the United States Food and Drug Administration has removed the partial clinical hold on the Company's aldoxorubicin clinical trials.

20 Jan 2015

Caris Life Sciences launches Caris Centers of Excellence for Precision Medicine Network

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced the establishment of the Caris Centers of Excellence for Precision Medicine Network, and appointed John L. Marshall, M.D., as Chairman of the Network.

20 Jan 2015

Doctors carry out first organ transplant from UK newborn

The very first successful organ donation from a newborn carried out in the UK is reported in the Fetal & Neonatal Edition of Archives of Disease in Childhood.

20 Jan 2015

Medical News

Researchers identify ten new antibodies that can possibly prevent cancer tumours

Study on influenza B viruses could help make flu vaccination programs more effective

EvergreenHealth recognized as Distinguished Hospital for Clinical Excellence

LUME-Lung 1 shows QoL, symptoms benefits

Amrubicin, carboplatin duo efficacious in thymic carcinoma, not invasive thymoma

MET amplified in NSCLC irrespective of type, genetic background

Rare, complex EGFR mutations adversely affect EGFR–TKI treatment outcomes

Income, race and ethnic origin may play more potent roles in asthma risk

Kinex Pharmaceuticals doses first actinic keratosis patient with KX2-391 ointment

NeoDeck, DataMotion partner for secure messaging of clinical and non-clinical information

TPI obtains GMP certification for Qionglai Tianyin Facility

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

EarlySense completes $20 million financing round

Celator Pharmaceuticals' CPX-351 receives FDA Fast Track designation for secondary AML treatment

Researchers explore how M6P deficiency affects different kinds of immune cells

UPM researchers study stability of arsenic species in edible marine algae

St. Luke’s offers Frameless Stereotactic Radiosurgery for treatment of brain tumors

FDA removes partial clinical hold on CytRx's aldoxorubicin clinical trials

Caris Life Sciences launches Caris Centers of Excellence for Precision Medicine Network

Doctors carry out first organ transplant from UK newborn

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News